STAT July 31, 2023
Adam Feuerstein and Matthew Herper

STAT readers know Vivek Ramaswamy from his time as the founder of the biotech conglomerate Roivant — and for his role in some of its various subsidiaries and spinoffs. Of course, the world now knows Ramaswamy for a very different reason: He’s running for president, and has made the cut to participate in the first debate of the Republican primary.

Earlier this month, Ramaswamy posted a video on Twitter trading on his biotech bona fides to talk about his plans to “expose and ultimately gut” the Food and Drug Administration.

“And when it comes to agencies like the FDA, boy, do I know their corruption,” said Ramaswamy.

Not surprisingly, as reporters who have both followed Ramaswamy for years and reported...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article